Literature DB >> 15610642

Stroke prevention in atrial fibrillation: warfarin faces its challengers.

Joseph L Blackshear1, Fred Kusumoto.   

Abstract

Warfarin is exceedingly effective and underutilized in treating atrial fibrillation. Recently completed studies of alternative therapies include trials of ximelagatran versus warfarin, antiplatelet therapy plus lower-intensity warfarin versus usual warfarin, and strategies of rhythm versus rate control. Results of these studies suggest new options for treatment, and caveats regarding those who appear to have durable sinus rhythm. Ongoing trials include studies of combined antiplatelet therapy and other antithrombins. Nonpharmacologic approaches include the Maze III procedure and similar operations, left atrial appendage obliteration, and catheter-based radiofrequency ablation procedures. The place of these latter therapies will only be defined through subsequent clinical trials.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15610642     DOI： 10.1007/s11886-005-0005-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  46 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy.

Authors:  Eduardo B Saad; Antonio Rossillo; Cynthia P Saad; David O Martin; Mandeep Bhargava; Demet Erciyes; Dianna Bash; Michelle Williams-Andrews; Salwa Beheiry; Nassir F Marrouche; James Adams; Ennio Pisanò; Raffaele Fanelli; Domenico Potenza; Antonio Raviele; Aldo Bonso; Sakis Themistoclakis; Joannes Brachmann; Walid I Saliba; Robert A Schweikert; Andrea Natale
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

3.  The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures.

Authors:  Sunil M Prasad; Hersh S Maniar; Cindy J Camillo; Richard B Schuessler; John P Boineau; Thoralf M Sundt; James L Cox; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

4.  Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Authors:  E M Hylek; Y C Chang; S J Skates; R A Hughes; D E Singer
Journal:  Arch Intern Med       Date:  2000-06-12

5.  Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers.

Authors:  E P Gerstenfeld; P Guerra; P B Sparks; K Hattori; M D Lesh
Journal:  J Cardiovasc Electrophysiol       Date:  2001-08

6.  Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

Authors:  Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

Review 8.  Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.

Authors:  R G Hart; B S Boop; D C Anderson
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

9.  Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation.

Authors:  Joseph L Blackshear; W Dudley Johnson; John A Odell; Vickie S Baker; Mary Howard; Lesly Pearce; Christopher Stone; Douglas L Packer; Hartzell V Schaff
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  1 in total

Review 1.  Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.

Authors:  Francesco De Sensi; Tom De Potter; Alberto Cresti; Silva Severi; Günter Breithardt
Journal:  Cardiovasc Diagn Ther       Date:  2015-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.